Projects per year
Personal profile
Education
- 1987.09-1994.06 MD, School of Medicine, Taipei Medical University
Experience
- 2023.05.05- Adjunct Professor, School of Medicine, College of Medicine, Taipei Medical University
- 2022.06- Vice Superintendent, Taipei Cancer Center, Taipei Medical Uni versity
- 1996.06-2022.06 Doctor, Department of Medicine, Taipei Veterans General Hospital, Taiwan
- 1994.06-1996.06 Doctor, Yuanshan Branch, Taipei Veterans General Hospital
- Doctor, Taipei Medical University Hospital
Fingerprint
Dive into the research topics where Chao-Hua Chiu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Active
-
以液體活檢改善目前的低劑量電腦斷層肺癌篩檢計畫—癌症篩檢的精準醫學(1/3)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
-
Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC
Zhou, Q., Soo, R. A., Chang, G. C., Chiu, C. H., Hayashi, H., Kim, S. W., Teraoka, S., Goto, Y., Zhou, J., Ho-Fun Lee, V., Kim, D. W., Han, B., Chung Man Ho, J., Lin, C. C., Lu, S., Polli, A., Calella, A. M., Martini, J. F., Wong, C. H., Mok, T., & 2 others, May 2023, In: JTO Clinical and Research Reports. 4, 5, 100499.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Efficacy of different platforms in detecting EGFR mutations using cerebrospinal fluid cell-free DNA from non-small-cell lung cancer patients with leptomeningeal metastases
Chiang, C. L., Ho, H. L., Yeh, Y. C., Lee, C. C., Huang, H. C., Shen, C. I., Luo, Y. H., Chen, Y. M., Chiu, C. H. & Chou, T. Y., 2023, (Accepted/In press) In: Thoracic Cancer. 14, 14, p. 1251-1259 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study
Yang, J. C. H., Su, W. C., Chiu, C. H., Shiah, H. S., Lee, K. Y., Hsia, T. C., Uno, M., Crawford, N., Terakawa, H., Chen, W. C., Takayama, G., Hsu, C., Hong, Y., Saintilien, C., McGill, J. & Chang, G. C., 2023, (Accepted/In press) In: Investigational New Drugs. 41, 2, p. 306-316 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Old age and EGFR mutation status in inoperable early-stage non-small cell lung cancer patients receiving stereotactic ablative radiotherapy: A single institute experience of 71 patients in Taiwan
Wu, Y. H., Kang, Y. M., Hu, Y. W., Lan, K. L., Yen, S. H., Lai, T. Y., Lan, T. L., Chen, Y. M., Chiu, C. H., Luo, Y. H., Chao, H. S., Chiang, C. L., Shiao, T. H., Yang, C. N., Hsu, W. H., Wu, Y. C., Hsu, H. S., Hung, J. J., Huang, C. S., Hsu, P. K., & 1 others, Mar 2023, In: Thoracic Cancer. 14, 7, p. 654-661 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Prognosticators of osimertinib treatment outcomes in patients with EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis
Chiang, C. L., Ho, H. L., Yeh, Y. C., Lee, C. C., Huang, H. C., Shen, C. I., Luo, Y. H., Chen, Y. M., Chiu, C. H. & Chou, T. Y., Jan 2023, In: Journal of Cancer Research and Clinical Oncology. 149, 1, p. 5-14 10 p.Research output: Contribution to journal › Article › peer-review